nara lins meira quintão análise dos mecanismos envolvidos na ...

ROCHA E SILVA, M.; BERALDO, W.T.; ROSENFELD, G.. Bradykinin, a hypotensive
and smooth muscle stimulating factor released from plasma globulin by snake
venoms and by tripsin. Am. J. Physiol. v. 156, p. 261-273, 1949.
RODRIGUES, A.L.; SILVA, G.L.; MATEUSSI, A.S.; FERNANDES, E.S.; MIGUEL, O.G.;
YUNES, R.A.; CALIXTO, J.B.; SANTOS, A.R.S.. Involvement of monoaminergic
system in the antidepressant-like effect of the hydroalcoholic extract of
Siphocampylus verticillatus. Life Sci. v. 70, p. 1347-1358, 2002.
RODRIGUES-FILHO, R.; SANTOS, A.R.S.; BERTELLI, J.A.; CALIXTO, J.B.. Avulsion
injury of the rat brachial plexus triggers hyperalgesia and allodynia in the hindpaws:
a new model for the study of neuropathic pain. Brain Res. v. 982, n. 2, p. 186-194,
2003.
ROSENTHAL, A.. Multicomponent receptor for the GDNF/neurturin protein family.
Neural Notes. v. 3, p. 3-7, 1997.
RUPNIAK, N.M.J.; BOYCE, S.; WEBB, J.K.; WILLIAMS, A.R.; CARLSON, E.J.; HILL,
R.G.; BORKOWSKI, J.A.; HESS, J.F.. Effects of the bradykinin B1 receptor
antagonist des-Arg9-[Leu8]-BK and genetic disruption of the B2 receptor on
nociception in rats and mice. Pain. v. 71, p. 89-97, 1997.
RUSSO, C.M. e BROSE, W.G. Chronic pain. Ann. Rev. Med., v. 49, p. 123-133, 1998.
SAARMA, M.. GDNF recruits the signalling crew into lipid rafts. Trends Neurosci. v. 24,
n. 8, p. 427-429, 2001.
SABOURIN, T.; BASTIEN, L.; BACHVAROV, D.R.; MARCEAU, F.. Agonist-induced
translocation of the kinin B1 receptor to caveolae-related rafts. Mol. Pharmacol. v.
61, p. 546-553, 2002.
SACHS, D.; CUNHA, F.Q.; FERREIRA, S.H.. Peripheral analgesic blockade of
hypernociception: activation of argentine/NO/cGMP/protein kinase G/ATP-sensitive
K + channel pathway. Proc. Natl. Acad. Sci. USA. v. 101, p. 3680-3685, 2004.
SAH, D.W.; OSSIPO, M.H.; PORRECA, F.. Neurotrophic factors as novel therapeutics
for neuropathic pain. Nat. Rev. Drug Discov. v. 2, n. 6, p. 460-472, 2003.
SAMPAIO, E.P.; SARNO, E.N.; GALILLY, R.; COHN, Z.A.; KAPLAN, G.. Thalidomide
selectively inhibits tumor necrosis factor alpha production by stimulated human
monocytes. J. Exp. Med. v. 173, p. 699-703, 1991.